Reason for the update: New clinical data readout The most recent clinical data from NewAmsterdam Pharma (NASDAQ:NAMS) has showcased the potential of obicetrapib in...
U.S. stocks ended mostly higher on Monday as Treasury yields hit more multi-year highs and lawmakers averted a shutdown of the federal government over...